AlphaStocks
4.9
Weak

HUMANA INC (HUM)

Health Care / Managed Health Care

S&P 500

$360.85

Below average on several measures. Research carefully.

Weak

Score based on 5 of 5 models — high confidence

#577out of 1123 in Health Care

Is HUMANA INC a Good Investment in 2026?

HUMANA INC (HUM) scores 4.9 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates HUMANA INC as Attractive (6/9). However, the Buffett model rates it Caution. HUMANA INC currently trades above its estimated fair value of $322, suggesting limited upside at current prices. HUMANA INC ranks #577 out of 1123 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E36.7ROE6.6Market Cap44BDiv Yield1.5

Estimated Fair Value

$322.0212% above

Trading slightly above estimated fair value.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/9

Buffett

Caution

Business quality & competitive moat

Graham

Neutral

34% above fair value

Lynch

Neutral

PEG 4.0 · Stalwart

Greenblatt

Neutral

Bottom half (rank 54%)

Frequently Asked Questions

Is HUMANA INC (HUM) a good investment?
Based on AlphaStocks' composite analysis, HUMANA INC (HUM) scores 4.9 out of 10, earning a Weak rating. This score is below average, suggesting caution. Trading slightly above estimated fair value.
What is HUMANA INC's Piotroski F-Score?
HUMANA INC's Piotroski F-Score status is Attractive. The raw score is 6/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is HUM overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $322, HUM appears overvalued. The stock currently trades 12% above its estimated fair value. Trading slightly above estimated fair value.
How does HUM compare to other Health Care stocks?
HUMANA INC ranks #577 out of 1123 stocks in the Health Care sector, placing it in the top 51% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about HUM?
AlphaStocks evaluates HUM using five proven investment models. Piotroski: Attractive; Buffett: Caution; Graham: Neutral; Lynch: Neutral; Greenblatt Magic Formula: Neutral. These models are combined into a single composite score of 4.9/10.

Similar Stocks

BFAMPARRAZN

Compare HUM with

HUM vs BFAMHUM vs PARRHUM vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer